Recombinant Human Epidermal Growth Factor Derivative (Shenzhen Wastin Genetech)

重组人表皮生长因子(深圳市华生元基因工程)

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant Human Epidermal Growth Factor Derivative (Shenzhen Wastin Genetech)
Drug Alias Name重组表皮生长因子衍生物 - Uni-Bio Science Group重组人表皮生长因子外用溶液金因肽GeneTimerEGF
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionEpidermal growth factor receptor erbB1 modulators
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsWounds and Injuries
Global Approved IndicationsWounds and Injuries
Approved Indications in ChinaWounds and Injuries
Original Approved Country/TerritoryMainland China
Original Approved Date2001/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Watsin Genetech Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Inactive CompaniesN/A
Active IndicationsWounds and Injuries
Inactive IndicationsN/A

Other Information

ATC CodeD03
Related LinksN/A